V Luxco S.A R.L. Versant's Net Worth

-$2.76 Million

Estimate Recalculated Jun 21, 2024 03:23PM EST

Who is V Luxco S.A R.L. Versant?

V Luxco S.A R.L. Versant does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Aprea Therapeutics, Inc..

SEC CIK

V Luxco S.A R.L. Versant's CIK is 0001786141

Past Insider Trading and Trends

2020 was V Luxco S.A R.L. Versant's most active year for acquiring shares with 6 total transactions. V Luxco S.A R.L. Versant's most active month to acquire stocks was the month of March. 2020 was V Luxco S.A R.L. Versant's most active year for disposing of shares, totalling 7 transactions. V Luxco S.A R.L. Versant's most active month to dispose stocks was the month of April. 2019 saw V Luxco S.A R.L. Versant paying a total of $4,999,995.00 for 2,839,986 shares, this is the most they've acquired in one year. In 2020 V Luxco S.A R.L. Versant cashed out on 3,418,692 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Aprea Therapeutics, Inc. (APRE) Snapshot price: $6.713

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.50%
-881.76K
—
—
4.16M
Apr 9 - May 18
Form 4
+22,415.04%
2.84M
$15.00
$4,999,995.00
2.85M
Oct 7
Form 3
—
0
—
—
0
No matching records found